The deletion variant of a2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.
Journal of the neurological sciences 2013 Mar .
Koutroumani M, Daniilidou M, Giannakouros T, Proitsi P, Liapi D, Germanou A, Nikolakaki E, Tsolaki M
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: